Flexion is a specialty pharmaceutical company focused on the development and commercialization of novel, local therapies for the treatment of patients with musculoskeletal conditions, beginning with osteoarthritis (OA). The company's lead product candidate, Zilretta™ (FX006), is an extended release intra-articular, analgesic candidate in late stage development for moderate to severe osteoarthritis pain.